Working… Menu

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01470794
Recruitment Status : Completed
First Posted : November 11, 2011
Last Update Posted : May 21, 2018
Information provided by (Responsible Party):
Tocagen Inc.